NEW YORK ( TheStreet) -- Given Imaging (Nasdaq: GIVN) has been upgraded by TheStreet Ratings from hold to buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

Given Imaging Ltd. develops, manufactures, and markets diagnostic products for the visualization and detection of gastrointestinal tract disorders. The company offers Given System, a wireless imaging system that uses PillCam capsules, which are disposable video capsules. The company has a P/E ratio of 40.8, below the average health services industry P/E ratio of 56.4 and above the S&P 500 P/E ratio of 23.3. Given Imaging has a market cap of $571 million and is part of the health care sector and health services industry. Shares are up 31.6% year to date as of the close of trading on Wednesday.

You can view the full Given Imaging Ratings Report or get investment ideas from our investment research center.
null

If you liked this article you might like

Covidien Looks Fully Valued

Covidien Scopes Out Medical Technology Growth

Jim Cramer's 6 Stocks in 60 Seconds: CELG CRM ATHN LULU LMT GIVN (Update 1)

Stocks Inch Higher as Chinese Exports Boost Global Markets

Chinese Data Lead Off U.S. Market Action